clinical AF" or "had atrial high rate events AHRE"). In MOST trial, AHRE were seen in almost 50% of patients treated for sinus node dysfunctionand were associated with an increased risk of stroke (1.69% per year if CHADS score>2) in ASSERT study. Nevertheless currently there are no antithrombotic recommendations for these patients. We tried to describe the different therapeutic alternatives in usual practice.
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Septal right ventricular lead positioning and optimized DDD pacing versus intrinsic conduction in sinus node disease: an echocardiographic study. The optimist trial Philippe Mabo (1), Daniel Gras (2), B.Degand (3), J.Dupuis (4), A.Pellissier (5), Aude Solnon (6), Erwan Donal (1) (1) CHU Rennes, Cardiologie, Rennes, Nouvelles Cliniques Nantaises, Cardiologie, Nantes, CHU Poitiers, Cardiologie, Poitiers, CHU Angers, Cardiologie, Angers, CHU Caen, Cardiologie, Caen, CHU Nantes, Cardiologie, Nantes, France Introduction: Preserved intrinsic conduction in paced sinus node disease (SND) patients seems to be associated with a better outcome when compared with apical right ventricular (RV) DDD pacing.The prospective, multicenter, randomized OPTIMIST study was designed to compare RV lead positioning in the septum to preserved intrinsic conduction in chronically paced SND patients.
Methods: SND patients with a class I indication were implanted with a DDD pacemaker (St. Jude medical), the RV lead being located in the midseptum. The algorithm VIP™ (Ventricular Intrinsic Preference) was programmed « on » in all patients at hospital discharge. After a 6 weeks observational period, patients with a ventricular pacing percentage inferior to 10% were randomized in 2 parallel groups: VIP « on » (preserved natural conduction -group 1) or « off » with AV delay optimization (RV pacing -group 2). Patients were followed every 6 months with echocardiography through 18 months. The primary endpoint was the left ventricular end-systolic diameter (LVESD) (Corelab analysis), with a non inferiority hypothesis.
Results: 216 patients mean age 76.07±9.45 were included and 167 randomized. The baseline characteristics were comparable in group 1 and 2 including left ventricular ejection fraction, LVEF (62.4±12.6 vs 64.4±8.7%), LVESD (32.7±8.5 vs 32.5±9.3mm) and 6 weeks RV pacing percentage (1.81±1.92 vs 2.15±2.07%). At the end of FU, as expected the percentage of RV pacing was significantly higher in group 2 (78.9±31.6 vs 7.9±17.4%). The LVEF was 62.3±10.1% in group 1 and 60.9±10.9% in group 2 (NS) and the LVESD was 31.9±7.23mm in group 1 and 31.26±7.21mm in group 2 (NS). The non-inferiority hypothesis was validated (p=2.572e-06 for a delta = 4.785). AF burden was not different between the 2 groups.
Conclusion:
When implanting the RV lead in the midseptum, DDD pacing with high percentage of RV capture was not associated with LV echocardiographic deterioration as compared to preserved intrinsic conduction pacing mode.
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Heart rate predicts long-term mortality as well as classical risk factors Florent Séguro (1), Emilie Bérard (2), Vanina Bongard (2), Jean-Bernard Ruidavets (2), Dorota Taraszkiewicz (1), Michel Galinier (3), Didier Carrié (1), Jean Ferrières (1 Background: Resting heart rate (RHR) is known as a cardiovascular risk factor (RF), correlated with hypertension, cardiac failure and coronary artery disease. The aim of this study was to assess the risk of all-cause mortality in a general population in a prediction algorithm including RHR as an independent parameter.
Methods: Our study population consisted in patients, both women and men, who had consulted from 1995 to 2011 to the Department of Preventive Cardiology (DPC) in a Southwestern French University Hospital. We excluded patients whose age was less than 30 years old and all patients with established history of ischemic heart disease. An algorithm for prediction of risk of mortality in primary prevention was built using Kaplan-Meier statistic and a Cox proportional hazards model. 
